Venetoclax
About
Therapy type: Targeted therapy
Therapy strategy: BCL2 inhibition
Mappings
NCI Thesaurus: Venetoclax (ncit:C103147)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.| Type | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| Sensitivity (+) | TP53 somatic variants | Chronic Lymphocytic Leukemia | Venetoclax | |
| Sensitivity (+) | TP53 deletion | Chronic Lymphocytic Leukemia | Venetoclax | |
| Sensitivity (+) | 17p deletion | Chronic Lymphocytic Leukemia | Venetoclax | |
| Sensitivity (+) | 17p deletion | Chronic Lymphocytic Leukemia | Venetoclax | |
| Sensitivity (+) | Wild type TP53 | Chronic Lymphocytic Leukemia | Venetoclax | |
| Sensitivity (+) | TP53 somatic variants | Chronic Lymphocytic Leukemia | Venetoclax | |
| Sensitivity (+) | TP53 deletion | Chronic Lymphocytic Leukemia | Venetoclax | |
| Sensitivity (+) | 17p deletion | Chronic Lymphocytic Leukemia | Venetoclax | |
| Sensitivity (+) | Wild type TP53 | Chronic Lymphocytic Leukemia | Venetoclax |